Determinants of white-coat hypertension

被引：72

作者：

Dolan, E

Stanton, A

Atkins, N

Den Hond, E

Thijs, L

McCormack, P

Staessen, J

O'Brien, E ^{[1
]}

机构：

[1] Beaumont Hosp, ADAPT Syst, Dublin 9, Ireland

[2] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland

[3] Katholieke Univ Leuven, UZ Gasthuisberg, Louvain, Belgium

来源：

BLOOD PRESSURE MONITORING | 2004年 / 9卷 / 06期

关键词：

white-coat hypertension; ambulatory blood pressure measurement; clinic blood pressure measurement; clinical characteristics;

D O I：

10.1097/00126097-200412000-00007

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Background The prevalence of white-coat hypertension (WCH) is considerable in patients referred with elevated office blood pressure. Failure to recognise this phenomenon can lead to the inappropriate use of anti hypertensive medications. We undertook this study to determine the profile of patients with WCH. Methods Baseline clinic and daytime ambulatory blood pressures were available from 5716 patients referred over a 22-year period. Individuals were considered to have WCH if they had an elevated clinic blood pressure measurement greater than 140/90 mmHg and normal daytime mean ambulatory blood pressure. Mean age was 53.6 years and 53.2% were female. Results The overall prevalence of white-coat hypertension was 15.4%. A higher prevalence was seen amongst older adults, females, and non-smokers. Conclusion Multivariate logistic regression analysis confirmed these characteristics as independent predictors of WCH. (C) 2004 Lippincott Williams Wilkins.

引用

页码：307 / 309

页数：3

共 16 条

[1]

ATKINS N, 1994, J HYPERTENS, V12, pS23

[2] Cardiovascular risk in white-coat and sustained hypertensive patients [J].